| |
| |
|
| Insider
Information: |
Hansen John David |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
190,827 |
|
|
Indirect Shares
|
15,000 |
|
|
| Direct
Value |
$4,389 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
205,827 |
|
|
| Total
Value |
$4,389 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
V.P. of Corporate Deve... |
2004-09-13 |
0 |
2005-01-03 |
15,000 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
|
2018-04-02 |
190,827 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2018-04-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,689) |
190,827 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2018-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,561 |
195,516 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2018-01-16 |
4 |
S |
$0.92 |
$54,522 |
D/D |
(59,263) |
536,730 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2018-01-12 |
4 |
S |
$0.96 |
$17,839 |
D/D |
(18,582) |
595,993 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2018-01-11 |
4 |
S |
$0.98 |
$62,735 |
D/D |
(64,015) |
614,575 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2018-01-10 |
4 |
S |
$0.96 |
$105,689 |
D/D |
(110,093) |
678,590 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2018-01-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
727,210 |
788,683 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-05-19 |
4 |
B |
$0.00 |
$7,501 |
D/D |
9,128 |
70,601 |
0.01 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-12 |
4 |
S |
$2.00 |
$20,433 |
D/D |
(10,216) |
61,473 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-11 |
4 |
S |
$2.00 |
$500 |
D/D |
(250) |
71,689 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-10 |
4 |
S |
$2.00 |
$1,120 |
D/D |
(560) |
71,939 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-07 |
4 |
S |
$2.01 |
$1,335 |
D/D |
(666) |
72,499 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-06 |
4 |
S |
$2.15 |
$3,223 |
D/D |
(1,501) |
73,165 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-05 |
4 |
S |
$2.15 |
$5,271 |
D/D |
(2,450) |
74,666 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-04 |
4 |
S |
$2.25 |
$2,475 |
D/D |
(1,100) |
77,116 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,687 |
78,216 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2016-08-17 |
4 |
B |
$0.00 |
$0 |
D/D |
3,119 |
37,529 |
0.01 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2016-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(113,148) |
254,634 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
PRESIDENT AND CEO |
• • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
301,084 |
367,782 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
President and CEOOfficer |
• • – |
2014-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
533,589 |
|
- |
|
| AVNR |
Avanir Pharmaceuticals |
V.P. of Corporate Development |
• – – |
2005-01-03 |
4 |
AS |
$3.39 |
$102,030 |
I/I |
(30,000) |
15,000 |
|
- |
|
| AVNR |
Avanir Pharmaceuticals |
V.P. of Corporate Development |
• – – |
2004-09-13 |
4 |
AS |
$3.15 |
$94,518 |
I/I |
(30,000) |
30,000 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
